Litigation Details for Novartis Pharmaceuticals Corporation v. Mylan Pharmaceuticals Inc. (N.D.W. Va. 2019)
✉ Email this page to a colleague
Novartis Pharmaceuticals Corporation v. Mylan Pharmaceuticals Inc. (N.D.W. Va. 2019)
| Docket | ⤷ Sign Up | Date Filed | 2019-10-30 |
| Court | District Court, N.D. West Virginia | Date Terminated | 2020-03-30 |
| Cause | 35:271 Patent Infringement | Assigned To | Thomas Shawn Kleeh |
| Jury Demand | Referred To | ||
| Patents | 8,877,938; 9,388,134 | ||
| Link to Docket | External link to docket | ||
Details for Novartis Pharmaceuticals Corporation v. Mylan Pharmaceuticals Inc. (N.D.W. Va. 2019)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2023-07-06 | 136 | Memorandum & Opinion | of United States Patent No. 8,877,938 (the “‘938 Patent”) and claim 5 of Patent No. 9,388,134 (the…the ‘938 Patent, it also infringes claim 11 of the ‘938 patent and claim 5 of the ‘134 Patent. The asserted…’938 patent claim 1, then Mylan will also infringe the ’938 patent claim 11 and the ’134 patent claim…938 patent claim 1, then Mylan will also infringe the ’938 patent claim 11 and the ’134 patent claim…States any patented invention during the term of the patent therefor, infringes the patent.” 35 U.S.C | External link to document |
| 2024-01-31 | 162 | Memorandum & Opinion | of United States Patent No. 8,877,938 (the “‘938 Patent”) and claim 5 of Patent No. 9,388,134 (the…the ‘938 Patent, it also infringes claim 11 of the ‘938 patent and claim 5 of the ‘134 Patent. The asserted…’938 patent claim 1, then Mylan will also infringe the ’938 patent claim 11 and the ’134 patent claim…938 patent claim 1, then Mylan will also infringe the ’938 patent claim 11 and the ’134 patent claim…States any patented invention during the term of the patent therefor, infringes the patent.” 35 U.S.C | External link to document |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
